NCT04983836

Brief Summary

Currently, the 2 main techniques of regional loco anesthesia in perioperative analgesic management of the thoracotomy remains the establishment of a thoracic epidural or paravertebral block. On the other hand, there is no standard of perioperative analgesic management in the case of thoracic surgery under video-thoracoscopy. The video-thoracoscopy, by its mini-invasive character, makes the levels of pain lower in post-operative questioning the benefit/risk balance of the paravertebral block. In 2013, Blanco published a new technique of locoregional anesthesia called the block Serratus allowing analgesia of a homolateral thorax hemi The latter by its simplicity of realization and its lesser risk is growing in thoracic surgery. This pilot study finds an equivalence in total oxycodone consumption in the first 2 post-operative days with a number of complications related to the serratus block lower than the serratus block compared to the paravertebral block in preoperative surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 19, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 30, 2021

Completed
4 months until next milestone

Study Start

First participant enrolled

December 5, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2022

Completed
Last Updated

June 9, 2023

Status Verified

June 1, 2023

Enrollment Period

1 year

First QC Date

July 19, 2021

Last Update Submit

June 8, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain evaluation

    Assess the non-inferiority of the single-injection echo-guided serratus block, performed in video-thoracic surgery preoperative, on the post-operative mean pain during the first 48 hours, compared to the single-injection echo-guided paravertebral block with a simple numeric scale (from 0 to 10)

    48 hours after the surgery

Secondary Outcomes (4)

  • Walking test

    24 hours after the surgery

  • Post operative morphine dose Post operative administrated morphin dose

    48 hours after the surgery

  • Morphine side effect quantification

    48 hours after the surgery

  • Length of hospitalisation duration

    1 year

Study Arms (2)

Serratus Block

EXPERIMENTAL
Procedure: Serratus anesthesia technique

Paravertebral Block

OTHER
Procedure: Paravertebral anesthesia technique

Interventions

locoregional anaesthesia allowing analgesia of the hemi-thorax by ultrasound guided single injection of naropeine 5mg/ml

Serratus Block

Ultrasound guided single injection of of naropeine 5mg/ml dose into the paravertebral space next to the thoracic spine

Paravertebral Block

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> 18 years
  • Patient who has given their free, informed and signed consent
  • Social security affiliation;

You may not qualify if:

  • pregnant woman
  • guardianship / curatorship / private patient under public law
  • surgery to be performed urgently (less than 24 hours)
  • surgery redux
  • thoracotomy surgery
  • sternotomy surgery
  • pleurectomy
  • patient participating simultaneously in another research that may interfere with results of the study
  • severe abnormality of haemostasis (80,000/ml platelets) and/or coagulation (TP 50%, factor V 50%).
  • Prior use of morphine;
  • chronic pain/chest neuropathies
  • sepsis
  • patients with insulin-dependent diabetes and/or diabetic neuropathy.
  • severe kidney or liver failure.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de NICE

Nice, Toutes, 06000, France

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Prospective, comparative, monocentric, randomized non-inferiority interventional study, in double-blind.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 19, 2021

First Posted

July 30, 2021

Study Start

December 5, 2021

Primary Completion

December 15, 2022

Study Completion

December 15, 2022

Last Updated

June 9, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

No data sharing in planned

Locations